alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Mental Health Initial Review Group; Mental Health Services Study Section.                    

*Date:*                         June 7-8, 2022.                    

*Time:*                         11:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).                    

*Contact Person:*                         Aileen Schulte, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, Neuroscience Center, 6001 Executive Blvd., Room 6136, MSC 9606, Bethesda, MD 20852, 301-443-1225,                         *aschulte@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS)

Dated: May 4, 2022. 

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-09884 Filed 5-6-22; 8:45 am]

BILLING CODE 4140-01-P
EX-10.28





 Exhibit 10.28 

July 23, 2018 
 Medallion Bank 

1100 East 6600 South, Suite 510 
 Salt Lake City, UT 84121 

Attention: Justin Haley 
  

	Re:	 8th Amendment Lease Commencement



 Dear Justin, 
 Please be advised that the
initial rent commencement date indicated in the 8th Amendment, which was August 1, 2018, will now be September 1, 2018 due to uncontrollable delays with the termination of the existing tenants 3rd floor expansion space, suite 310 & 320
(3,303 square feet). The rent schedule listed in the amendment will be revised with the correct start date and continue as indicated below. 
  

									
	 Periods
	  	Base Rent	 	  	Annual Cost Per
Rentable Square Foot	 
	 September 1, 2018 through November 30, 2018, inclusive
	  	$	25,350.00 per month	 	  	$	24.00	 
			
	 December 1, 2018 through November 30, 2019, inclusive
	  	$	26,110.50 per month	 	  	$	24.72	 
			
	 December 1, 2019 through November 30, 2020, inclusive
	  	$	26,892.13 per month	 	  	$	25.46	 
			
	 December 1, 2020 through November 30, 2021, inclusive
	  	$	27,705.44 per month	 	  	$	26.23	 
			
	 December 1, 2021 through November 30, 2022, inclusive
	  	$	28,529.31 per month	 	  	$	27.01	 
			
	 December 1, 2022 through November 30, 2023, inclusive
	  	$	29,384.88 per month	 	  	$	27.82	 

 Please keep a copy of this letter for you records and if you have any questions please do not hesitate to let us know. 

Very truly yours, 
 Mountain High Real Estate Advisors, Inc.

  
 



 
 Ian L. Galanis, 
 Vice
President
##### 



Exhibit 11.1

IPC HOLDINGS, LTD. AND SUBSIDIARIES
RECONCILIATION OF BASIC AND DILUTED NET INCOME PER COMMON SHARE
(Expressed in thousands of United States dollars, except for share amounts)

A reconciliation of basic and diluted earnings per share (EPS) is given in
the following table:

|                                 |  |             |        |                 |  |            |            |  |  |   |      | 
|-------------------------------- |  | ----------- | ------ | --------------- |  | ---------- | ---------- |  |  | - | ---- | 
|                                 |  |             |        |                 |  | Shares     |            |  |  |  
|                                 |  | Income      |        | outstanding     |  | Amount per
|                                 |  | (unaudited) |        | and equivalents |  | Share     
|                                 |  |             |        |                 |  |           
|Quarter ended September 30, 2003 |  |             |        |                 |  |            |            |  |  |   |      | 
|Basic EPS                        |  | $           | 62,132 |                 |  |            | 48,214,793 |  |  | $ | 1.29 | 
|Diluted EPS                      |  | $           | 62,132 |                 |  |            | 48,300,348 |  |  | $ | 1.29 | 
|Quarter ended September 30, 2002 |  |             |        |                 |  |            |            |  |  |   |      | 
|Basic EPS                        |  | $           | 45,783 |                 |  |            | 48,172,776 |  |  | $ | 0.95 | 
|Diluted EPS                      |  | $           | 45,783 |                 |  |            | 48,265,409 |  |  | $ | 0.95 | 

|                                     |  |             |         |                 |  |            |            |  |  |   |      | 
|------------------------------------ |  | ----------- | ------- | --------------- |  | ---------- | ---------- |  |  | - | ---- | 
|                                     |  |             |         |                 |  | Shares     |            |  |  |  
|                                     |  | Income      |         | outstanding     |  | Amount per
|                                     |  | (unaudited) |         | and equivalents |  | Share     
|                                     |  |             |         |                 |  |           
|Nine months ended September 30, 2003 |  |             |         |                 |  |            |            |  |  |   |      | 
|Basic EPS                            |  | $           | 195,248 |                 |  |            | 48,194,170 |  |  | $ | 4.05 | 
|Diluted EPS                          |  | $           | 195,248 |                 |  |            | 48,280,373 |  |  | $ | 4.04 | 
|Nine months ended September 30, 2002 |  |             |         |                 |  |            |            |  |  |   |      | 
|Basic EPS                            |  | $           | 137,936 |                 |  |            | 48,172,776 |  |  | $ | 2.86 | 
|Diluted EPS                          |  | $           | 137,936 |                 |  |            | 48,267,844 |  |  | $ | 2.86 | 

20
Exhibit








AXA EQUITABLE HOLDINGS, INC.
AXA EQUITABLE LIFE INSURANCE COMPANY






February 27, 2019




Mr. Mark Pearson 
AXA Equitable Holdings, Inc. 
1290 Avenue of the Americas, 16th floor 
New York, New York 10104 


Dear Mr. Pearson: 


This letter confirms our understanding regarding the amendment of Section 7(c)(ii) of your employment agreement dated March 9, 2011 (the “Agreement”).  Please confirm your acceptance of the terms of this letter by signing below. 


The Agreement provides that you will be eligible to receive certain severance benefits if you terminate within 180 days after the effective date of a “change in control.”  We have agreed that the definition of change in control for purposes of the Agreement should be amended to follow the definition in the AXA Equitable Supplemental Severance Plan for Executives.  Accordingly, Section 7(c)(ii) of the Agreement will amended to read as follows:


“termination of employment by the Executive in the event of a Change in Control (as hereinafter defined) of the Company upon 30 days’ written notice, provided that the Executive must deliver such notice to the Company within 180 days after the effective date of any such Change in Control. For purposes of this Section 7(c)(ii), “Change in Control” shall have the same meaning as set forth in the AXA Equitable Supplemental Severance Plan for Executives, as amended from time to time.”


 By signing below, you indicate your acceptance of, and agreement with, this amendment.




Sincerely,


	
	
	/s/ Jeff Hurd

	Jeff Hurd

	Chief Operating Officer

	AXA Equitable Holdings, Inc.

	AXA Equitable Life Insurance Company






	
	
	ACCEPTED AND AGREED TO:

	 

	/s/ Mark Pearson

	Mark Pearson
ex_137071.htm


Exhibit 10.8


 


AMENDMENT #1


 


TO THE $495,000 PROMISSORY NOTE DATED JANUARY 31, 2018


 


 


The parties agree that the $495,000 Convertible Promissory Note (the “Note”) by and between BioLargo, Inc. (the “Borrower”) and Tangiers Global, LLC (the “Lender”) is hereby amended as follows:


 


	
			1.

				
			Payment. The Lender shall make a payment to the Borrower $150,000 of Consideration, plus $15,000 in an OID under the Note on or before March 4, 2019.

			
	 	 
	
			2.

				
			Use of Proceeds. The Company covenants that it will within, three months of the Effective Date of this Consideration, it shall use approximately $150,000 of the proceeds in the manner set forth below (the “Use of Proceeds”): general working capital.

			
	 	 
	
			3.

				
			Independent Transactions. The Borrower understands and agrees that the Note sets forth the terms for a series of independent transactions in which the Lender may elect to make a payment of Consideration to the Borrower with each payment of Consideration creating a separate obligation of the Borrower to the Lender with the terms set forth in the Note. Accordingly, the Maturity Date of each payment of Consideration, and the repayment terms for each payment of Consideration, are as set forth in the Note.

			
	 	 
	
			4.

				
			The Borrower confirms that it has not undertaken any capital raise, whether through debt or equity, with any other party since the Effective Date of the Note.

			



 


ALL OTHER TERMS AND CONDITIONS OF THE NOTE REMAIN IN FULL FORCE AND EFFECT.


 


Please indicate acceptance and approval of this amendment dated March 5, 2019 by signing below:


 


	
			/s/Dennis P. Calvert

				 	
			/s/Justin Ederle

				 
	 	 	 	 
	
			BioLargo, Inc.

				 	
			Tangiers Global, LLC

				 
	 	 	 	 
	
			By: Dennis P. Calvert

				 	
			By: Justin Ederle

				 
	 	 	 	 
	
			Its: President

				 	
			Its: Managing Member

				 
	 	 	 	 
	
			Date: March 5, 2019

				 	
			Date: March 6, 2019

				 



 



 




 




 


DISBURSEMENT INSTRUCTIONS


 


	 	
			TO:

				
			Tangiers Global, LLC

			



 


	 	
			FROM:

				
			BioLargo, Inc.

			



      


	 	
			DATE:

				
			March 4, 2019

			



 


Pursuant to that certain Convertible Promissory Note between the parties listed above and dated January 31, 2019, a disbursement of funds will take place in the amount and manner described below:


 


	
			Please disburse to:

				 
	
			Amount to disburse:

				
			$150,000

			
	
			Form of distribution

				
			Wire

			
	
			Name

				
			BioLargo, Inc.

			
	
			Address


			 


			 

				
			 


			 

			
	
			Wire Instructions:

				
			 


			FBO: BioLargo, Inc.


			Account #: 001549768543


			ABA Routing #:026-00-9593


			Bank of America, attention: Branch Manager


			Address: 24211 Paseo De Valencia, Laguna Hills, CA 92653


			Phone: 949-951-4076


			 

			



 


TOTAL: $150,000


 


BioLargo, Inc.


 


 


By: _________________________________________     Dated: March 5, 2019


 


Name: Dennis P. Calvert


 


Its: President
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AND THE CONSOLIDATED STATEMENT OF INCOME FILED AS
PART OF THE QUARTERLY REPORT ON FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH QUARTERLY REPORT ON FORM 10-Q
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JAN-31-1998
<PERIOD-START>                              FEB-2-1997
<PERIOD-END>                                AUG-2-1997
<CASH>                                         133,142
<SECURITIES>                                         0
<RECEIVABLES>                                   59,249
<ALLOWANCES>                                     2,104
<INVENTORY>                                    129,570
<CURRENT-ASSETS>                               359,021
<PP&E>                                         222,450
<DEPRECIATION>                                 111,062
<TOTAL-ASSETS>                                 669,716
<CURRENT-LIABILITIES>                          355,287
<BONDS>                                        314,377
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                    (26,897)
<TOTAL-LIABILITY-AND-EQUITY>                   669,716
<SALES>                                        502,572
<TOTAL-REVENUES>                               502,572
<CGS>                                          171,122
<TOTAL-COSTS>                                  468,980
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              16,634
<INCOME-PRETAX>                                 16,958
<INCOME-TAX>                                     7,292
<INCOME-CONTINUING>                              9,666
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     9,666
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
DeMarius L. WILLIAMS, petitioner v. ILLINOIS.

No. 18-8578.

Supreme Court of the United States

May 28, 2019.

Petition for writ of certiorari to the Appellate Court of Illinois, Third District denied.
I

106TH CONGRESS

1ST SESSION H. R. 1700

To provide that a national missile defense system shall not be subject to

an otherwise applicable statutory requirement that a major defense acquisition program not proceed beyond low-rate initial production before

completion of initial operational test and evaluation and that an environmental impact statement prepared for the construction of any element

of such a system shall not be subject to judicial review.

IN THE HOUSE OF REPRESENTATIVES

MAY 5, 1999

Mr. HOSTETTLER (for himself, Mr. WELDON of Pennsylvania, Mr. MCINTOSH,

Mr. BARTLETT of Maryland, Mr. GREEN of Wisconsin, Mr. ADERHOLT,

Mr. PITTS, and Mr. BURTON of Indiana) introduced the following bill;

which was referred to the Committee on Armed Services, and in addition

to the Committee on Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions

as fall within the jurisdiction of the committee concerned

A BILL

To provide that a national missile defense system shall not

be subject to an otherwise applicable statutory requirement that a major defense acquisition program not proceed beyond low-rate initial production before completion

of initial operational test and evaluation and that an

environmental impact statement prepared for the construction of any element of such a system shall not

be subject to judicial review.
2

•HR 1700 IH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘National Missile De5 fense Expediency Act of 1999’’.

6 SEC. 2. WAIVER FOR NATIONAL MISSILE DEFENSE SYSTEM

7 OF REQUIREMENT FOR COMPLETION OF INI8 TIAL OPERATIONAL TEST AND EVALUATION

9 BEFORE PROCUREMENT BEGINS.

10 Section 2399(a) of title 10, United States Code, does

11 not apply to procurement for a national missile defense

12 system.

13 SEC. 3. LIMITATION ON JUDICIAL REVIEW REGARDING NA14 TIONAL MISSILE DEFENSE SYSTEM.

15 Any environmental impact statement prepared under

16 section 102(2)(C) of the National Environmental Policy

17 Act of 1969 (42 U.S.C. 4332(2)(C)) for construction of

18 any element of a national missile defense system shall not

19 be subject to judicial review.

Æ
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA

F OURTH D ISTRICT

TIMOTHY LEE HATTEN

, Appellant,

v.

STATE OF FLORIDA

, Appellee

.

No. 4D 20

- 1111

[ July 9, 2020 ]

Appeal of order denying rule 3.850 motion from the Circuit Court for

the Fifteenth Judicial Circuit ; Palm Beach County

, Jeffrey Dana Gillen, Judge; L.T. Case No. 501985CF006720BXXXMB

.

Timothy Lee Hatten, West Palm Beach, pro se.

No appearance required for appellee.

P ER C URIAM

.

Affirmed

.

W AR NER
, C IKLIN and K UNTZ , JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
David Raphael CONCEPCION, petitioner, v. UNITED STATES.

No. 18-8943.

Supreme Court of the United States

May 28, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
IN THE SUPREME COURT OF PENNSYLVANIA MIDDLE DISTRICT COMMONWEALTH OF PENNSYLVANIA, Respondent

v. JAMES EDWARD BUCK, SR., Petitioner : : : : : : : : : : : No. 148 MAL 2014 Petition for Allowance of Appeal from the Order of the Superior Court

ORDER PER CURIAM AND NOW , this 30th day of July, 2014, the Petition for Allow ance of Appeal is DENIED
.
# Официален вестник C 6A/6 ян

| | ISSN 1977-0855 |
| --- | --- |
| Официален вестник
  на Европейския съюз | C 6A |
| | |
| Издание на български език | Информация и известия | Година 656 януари 2022 г. |

ISSN 1977-0855

Официален вестник

на Европейския съюз

C 6A

Издание на български език

Информация и известия

Година 656 януари 2022 г.

---

| Съдържание | Страница |
| --- | --- |
| | Поправки |
| 2022/C 6 A/01 | Поправка на Обявление за конкурс на общо основание — EPSO/AD/396/21 — Юрист-лингвисти (AD 7) с ирландски език (GA) ( ОВ C 466 A, 18.11.2021 г. ) | 1 |

Съдържание

Страница

Поправки

2022/C 6 A/01

Поправка на Обявление за конкурс на общо основание — EPSO/AD/396/21 — Юрист-лингвисти (AD 7) с ирландски език (GA) ( ОВ C 466 A, 18.11.2021 г. )

( ОВ C 466 A, 18.11.2021 г. )

1

---

| BG | |
| --- | --- |

BG

---

Поправки

| 6.1.2022 | BG | Официален вестник на Европейския съюз | CA 6/1 |
| --- | --- | --- | --- |

6.1.2022

BG

Официален вестник на Европейския съюз

CA 6/1

---

Поправка на Обявление за конкурс на общо основание — EPSO/AD/396/21 — Юрист-лингвисти (AD 7) с ирландски език (GA)

(
  Официален вестник на Европейския съюз C 466 A от 18 ноември 2021 г.
  )

(2022/C 6 A/01)

На страница 1 под заглавието

| вместо: | „Краен срок за регистрация: 21 декември 2021 г., 12 ч. на обяд, брюкселско време“ |
| --- | --- |

вместо:

„Краен срок за регистрация: 21 декември 2021 г., 12 ч. на обяд, брюкселско време“

| да се чете: | „Краен срок за регистрация: 25 януари 2022 г., 12 ч. на обяд, люксембургско време.“ |
| --- | --- |

да се чете:

да се чете:

„Краен срок за регистрация: 25 януари 2022 г., 12 ч. на обяд, люксембургско време.“

На страница 5 последният параграф

| вместо: | „Кандидатствайте по електронен път на уебсайта на EPSO https://epso.europa.eu/job-opportunities до:

  21 декември 2021 г., 12 ч. на обяд, брюкселско време.“ |
| --- | --- |

вместо:

вместо:

„Кандидатствайте по електронен път на уебсайта на EPSO https://epso.europa.eu/job-opportunities до:

21 декември 2021 г., 12 ч. на обяд, брюкселско време.“

| да се чете: | „Кандидатствайте по електронен път на уебсайта на EPSO https://epso.europa.eu/job-opportunities до:

  25 януари 2022 г., 12 ч. на обяд, люксембургско време.“ |
| --- | --- |

да се чете:

да се чете:

„Кандидатствайте по електронен път на уебсайта на EPSO https://epso.europa.eu/job-opportunities до:

25 януари 2022 г., 12 ч. на обяд, люксембургско време.“

---
Anthony C. BARRETT, petitioner, v. UNITED STATES.

No. 18-8718.

Supreme Court of the United States

May 13, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
<PAGE>

                                                                    Exhibit 13.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Annual Report of Delta Galil Industries Ltd. (the
"Company") on Form 20-F for the period ending December 31, 2005, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned hereby certifies that to the best of his knowledge:

     1. The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Date:  June 28, 2006

     /S/ DOV LAUTMAN
---------------------------
   Dov Lautman
   Chairman of the Board of Directors and Chief Executive Officer
Edward Vincent RAY, petitioner, v. CALIFORNIA.

No. 18-5066.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the Supreme Court of California denied.
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and
Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. § 1350), Todd G. Simpson, PhD, Chief Executive Officer of Ditech
Networks, Inc. (the "Company"), and William J. Tamblyn, the Chief Financial Officer of the Company, each hereby certify that, to the best of his knowledge:

1.The Company's Annual Report on Form 10-K for the period ended April 30, 2008, and to which this
Certification is attached as Exhibit 32.1, (the "Periodic Report") fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934,
and

2.The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.

IN
WITNESS WHEREOF, the undersigned have set their hands hereto as of the 10th Day of July, 2008.

| |  | /s/TODD G. SIMPSON, PHDTodd G. Simpson, PhD CHIEF EXECUTIVE
OFFICER
| |  | -------------------------------------------------------------------
| |  | /s/WILLIAM J. TAMBLYNWilliam J. Tamblyn CHIEF FINANCIAL OFFICER    

The
foregoing certification is not filed with the Securities and Exchange Commission as part of the Form 10-K or as a separate disclosure document and is not
incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the
Form 10-K), irrespectively of any general incorporation language contained in such filing.

---



QuickLinks
Bruce L. SMALL, petitioner, v. FLORIDA.

No. 18-5284.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the District Court of Appeal of Florida, Third District denied.